Drug Discovery is an extremely arduous process. More than 60 percent of the known diseases remain untreatable because of the complex research framework involved in the development of new therapeutic drugs and therapies. However, many healthcare companies are making significant strides in the fields of gene and cell therapies, omics technology, and smart molecular approaches. These advances require cost and time-effective techniques that can provide meaningful insights into large databases to help develop effective therapies.
Healthcare companies are acknowledging the significance of leveraging an artificial intelligence-based platform that can appropriately use healthcare data in gene mutations, protein targets, signaling pathways, disease events, and clinical trials to figure out the hidden correlation between drug and disease. These platforms will allow scientists to derive structured and unstructured data from multiple sources to address new therapeutic areas. AI-based tools are empowering the pharmaceutical companies to develop precision medicine through a stratified therapeutics discovery and development approach. The collaboration between AI developers and drug manufacturers can be a path-breaking factor in treating rare and chronic diseases.
Some of the applications of AI-driven tolls for pharmaceuticals are as follows:
Drug Discovery: AI-based tools help in drug design and development. It also aids in disease modeling, lead identification, and drug repurposing.
Clinical Trials: AI-tools can offer significant insights into a pool of data through analysis. Healthcare companies can leverage this technology in clinical trials to analyze data, and report generation. These tools can also provide ideal support in all processes of clinical trials, from designing the trials to patient identification through data collection.
Precision medicine: precision medicine allows doctors to choose the best drug to treat a patient based on the genetic understanding of the disease. AI tools help to accelerate the development of precision medicine, treatment surveillance, and omics adaptive models.
Compliance Regulation: Pharmaceuticals companies have to abide by the HIPAA standards for any medical practice. AI tools facilitate all compliance regulations like approval of application and process, labeling, and safety updates.